MARKET NEWS AND UPDATES.
Get notified for Latest News and Market Alerts.
Get notified for Latest News and Market Alerts.
×
| Fund Name | : | UTI Mutual Fund |
| Scheme Name | : | UTI-Healthcare Fund - Direct Growth |
| AMC | : | UTI Mutual Fund |
| Type | : | Open |
| Category | : | Equity - Pharma |
| Launch Date | : | 01-Jan-13 |
| Fund Manager | : | V Srivatsa |
| Net Assets (Rs. cr) | : | 766.09 |
| 1w | 1m | 3m | 6m | 1y | 3y | 5y | Since INC | |
| Scheme Returns | 0.07 | [8.32] | [3.55] | [12.32] | [9.69] | 22.01 | 13.62 | 13.46 |
| Category Avg | [2.22] | [7.27] | [4.02] | [11.04] | [7.69] | 22.98 | 14.51 | 14 |
| Category Best | [1.30] | [5.97] | [2.57] | [8.76] | [3.41] | 28.15 | 18.26 | 23.86 |
| Category Worst | [3.15] | [8.12] | [5.65] | [12.87] | [11.20] | 18.53 | 11.25 | [12.70] |
| NAV Date | : | 26-May-22 |
| NAV [Rs.] | : | 156.41 |
| Buy/Resale Price [Rs.] | : | 0 |
| Sell/Repurchase Price [Rs.] | : | 0 |
| Entry Load % | : | |
| Exit Load % | : | Nil |
| Dividends | Bonus | |
| Ratio | NA | NA |
| Date | NA | NA |
| Min. Investment(Rs.) | : | 5000 |
| Increm.Investment(Rs.) | : | 1000 |
| In | |
| Name of the Company | No of shares |
| Abbott India | 6794 |
| Rainbow Child. | 184518 |
| Out | |
| Name of the Company | No of shares |
| FDC | 205305 |
| Asset Type | Instrument Name | Industry | Net Assets(%) | No of Shares | Mkt Value(Cr.) |
| Equity & Equity related Investments | |||||
| Equity | Sun Pharma.Inds. | Pharmaceuticals & Biotechnology | 10.71 | 883,786.00 | 82.07 |
| Equity | Dr Reddy's Labs | Pharmaceuticals & Biotechnology | 7.99 | 148,183.00 | 61.23 |
| Equity | Cipla | Pharmaceuticals & Biotechnology | 7.85 | 612,722.00 | 60.12 |
| Equity | Divi's Lab. | Pharmaceuticals & Biotechnology | 5.25 | 89,214.00 | 40.19 |
| Equity | Fortis Health. | Healthcare Services | 4.97 | 1,423,801.00 | 38.04 |
| Equity | Aurobindo Pharma | Pharmaceuticals & Biotechnology | 4.84 | 589,611.00 | 37.09 |
| Equity | Krishna Institu. | Healthcare Services | 4.14 | 236,578.00 | 31.70 |
| Equity | Lupin | Pharmaceuticals & Biotechnology | 3.96 | 407,073.00 | 30.31 |
| Equity | Ipca Labs. | Pharmaceuticals & Biotechnology | 3.70 | 280,294.00 | 28.36 |
| Equity | Biocon | Pharmaceuticals & Biotechnology | 3.70 | 769,146.00 | 28.34 |
| Equity | Apollo Hospitals | Healthcare Services | 3.24 | 55,804.00 | 24.86 |
| Equity | Ajanta Pharma | Pharmaceuticals & Biotechnology | 2.96 | 131,743.00 | 22.67 |
| Equity | Alembic Pharma | Pharmaceuticals & Biotechnology | 2.87 | 281,719.00 | 22.01 |
| Equity | Zydus Lifesci. | Pharmaceuticals & Biotechnology | 2.84 | 617,825.00 | 21.75 |
| Equity | ERIS Lifescience | Pharmaceuticals & Biotechnology | 2.73 | 307,182.00 | 20.92 |
| Equity | Suven Pharma | Pharmaceuticals & Biotechnology | 2.46 | 311,636.00 | 18.81 |
| Equity | Gland Pharma | Pharmaceuticals & Biotechnology | 2.33 | 55,696.00 | 17.83 |
| Equity | Narayana Hrudaya | Healthcare Services | 1.96 | 214,545.00 | 15.02 |
| Equity | Metropolis Healt | Healthcare Services | 1.95 | 62,224.00 | 14.92 |
| Equity | J B Chem & Pharm | Pharmaceuticals & Biotechnology | 1.93 | 85,934.00 | 14.77 |
| Equity | Alkem Lab | Pharmaceuticals & Biotechnology | 1.91 | 44,987.00 | 14.62 |
| Equity | Torrent Pharma. | Pharmaceuticals & Biotechnology | 1.71 | 46,417.00 | 13.06 |
| Equity | Poly Medicure | Healthcare Equipment & Supplies | 1.70 | 149,488.00 | 13.05 |
| Equity | Pfizer | Pharmaceuticals & Biotechnology | 1.64 | 28,572.00 | 12.53 |
| Equity | Ami Organics | Pharmaceuticals & Biotechnology | 1.60 | 107,981.00 | 12.25 |
| Equity | P & G Health Ltd | Pharmaceuticals & Biotechnology | 1.55 | 26,774.00 | 11.88 |
| Equity | Abbott India | Pharmaceuticals & Biotechnology | 1.51 | 6,794.00 | 11.60 |
| Equity | Advanced Enzyme | Agricultural Food & other Products | 1.34 | 338,469.00 | 10.23 |
| Equity | Rainbow Child. | Healthcare Services | 1.31 | 184,518.00 | 10 |
| Equity | Sequent Scien. | Pharmaceuticals & Biotechnology | 1.10 | 620,305.00 | 8.46 |
| Equity | Windlas Biotech | Pharmaceuticals & Biotechnology | 0.59 | 179,514.00 | 4.49 |
| Money Market Investments | |||||
| T Bills | R B I | -/- | 0.17 | 13,500,000.00 | 1.34 |
| Term Deposits | |||||
| Fixed Deposits | Indian Bank | -/- | 0.26 | 0.00 | 1.99 |
| Fixed Deposits | C C I | -/- | 0.02 | 0.00 | 0.17 |
| Cash & Cash Equivalent | |||||
| Net CA & Others | Net CA & Others | -/- | 1.23 | 0.00 | 9.39 |
| Fund House | : UTI Mutual Fund |
| Incorporation Date | : 14-Nov-2002 |
| Total Assets Managed (Cr.) | : 223,841.53 |
| Trustee/s | : UTI Tustee Company Pvt. L |
| Chairman | : N/A |
| CEO / MD | : Mr. Sandeep Vivek Sumsi |
| CIO | : N/A |
| President | : Mr. Debashish Mohanty |
| Director/s | : Mr. Flemming Madsen |
| Compliance Officer/s | : Ms. Suruchi wanare |
| Investor Service Officer/s | : Ms.Madhavi Dicholkar |
| Fund Manager/s | : V Srivatsa |
| Auditors | : S.R.Batliboi & co.LLp |
| Registered Office | : UTI Towers, Gn Block, Bandra Kurla Complex, Bandra (East), Mumbai 400 051 |
| Contact Nos | : 66786666 |
| Fax | : 66786503;66786578 |
| : service@uti.co.in | |
| Website | : www.utimf.com |
Growth will come back and people will take time to adjust, which is why we will spend the next 1-1.5 years in a consolidation phase....
Per Order for ETF & Mutual Funds Brokerage
Per Order for Delivery, Intraday, F&O, Currency & Commodity
